Aimee Cunningham
FDA investigator
Appears on 2 documents from 2017 to 2019, mostly at sites in Japan. Most often cites control of microbiological contamination (21 CFR 211.113).
- 2
- Documents on file
- 3.0
- Observations per 483
- 2017
- First seen
- 2019
- Most recent
What they cite most
From 6 observations- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.160General requirements1
- 21 CFR 211.192Production record review1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 211.56Sanitation1
- 21 CFR 211.68Automatic, mechanical, and electronic equipment1
Activity by year
2017: 1, 2019: 1
Where
Japan 1 · Massachusetts 1
Often inspects with
Is Aimee Cunningham coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2019-01-18 | 483 Wyeth BioPharma Division of Wyeth Pharmaceuticals LLCJan 18, 2019 · Andover, Massachusetts | Andover, Massachusetts | 1 | |
| 2017-09-01 | 483 Chugai Pharma Manufacturing Co., LtdSep 1, 2017 · Utsunomiya, Japan | Utsunomiya, Japan | 5 |
About this profile
What does Aimee Cunningham inspect?
Aimee Cunningham appears on 2 documents on file covering 2 sites, mostly in Japan.
What do they cite most often?
21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.160 and 21 CFR 211.192.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Aimee Cunningham is dated Jan 18, 2019.